Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

ImmunoPrecise Antibodies Q1 Sales $4.70M Beat $4.02M Estimate

ImmunoPrecise Antibodies (NASDAQ:IPA) reported quarterly sales of $4.70 million which beat the analyst consensus estimate of $4.02 million by 16.92 percent. This is a 25.87 percent increase over sales of $3.73 million
byBenzinga Newsdesk
September 14, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

ImmunoPrecise Antibodies (NASDAQ:IPA) reported quarterly sales of $4.70 million which beat the analyst consensus estimate of $4.02 million by 16.92 percent. This is a 25.87 percent increase over sales of $3.73 million the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts